Oliver Kepp Selected Research

pyrazolanthrone

1/2013	Transgenerational cell fate profiling: a method for the graphical presentation of complex cell cycle alterations.
6/2012	Selective killing of p53-deficient cancer cells by SP600125.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Oliver Kepp Research Topics

Disease

155	Neoplasms (Cancer) 01/2024 - 04/2003
14	Necrosis 01/2023 - 04/2009
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 03/2010
8	Lung Neoplasms (Lung Cancer) 11/2023 - 08/2012
7	Melanoma (Melanoma, Malignant) 01/2024 - 01/2018
6	Fibrosarcoma 11/2023 - 06/2013
6	Infections 01/2023 - 03/2009
6	Carcinogenesis 01/2022 - 03/2012
6	Carcinoma (Carcinomatosis) 02/2014 - 06/2012
5	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 05/2012
4	Lymphoma (Lymphomas) 10/2023 - 01/2019
4	Residual Neoplasm 01/2021 - 06/2010
4	Breast Neoplasms (Breast Cancer) 01/2019 - 05/2012
4	Tetraploidy 02/2014 - 04/2009
3	Inflammation (Inflammations) 01/2024 - 03/2012
3	Pain (Aches) 01/2024 - 01/2022
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2023 - 09/2013
3	Leukemia 10/2023 - 12/2016
3	Colonic Neoplasms (Colon Cancer) 01/2022 - 02/2014
3	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 01/2013
3	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2015
2	COVID-19 12/2021 - 01/2020
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021 - 01/2020
2	Cystic Fibrosis (Mucoviscidosis) 11/2019 - 01/2018
2	Polyploidy 02/2014 - 06/2012

Drug/Important Bio-Agent (IBA)

22	AntigensIBA 01/2024 - 10/2008
19	CalreticulinIBA 01/2022 - 02/2009
19	Adenosine Triphosphate (ATP)IBA 01/2022 - 10/2009
19	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2008
16	AnthracyclinesIBA 01/2021 - 10/2008
15	Antineoplastic Agents (Antineoplastics)IBA 11/2023 - 06/2012
11	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023 - 06/2010
11	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2010
10	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2017
10	HMGB1 Protein (HMG1)IBA 01/2022 - 10/2008
9	VaccinesIBA 01/2024 - 03/2012
8	Phosphotransferases (Kinase)IBA 01/2021 - 10/2009
7	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 04/2009
5	AntibodiesIBA 01/2024 - 01/2019
5	Local AnestheticsIBA 01/2024 - 01/2021
5	Neoplasm Antigens (Tumor Antigens)IBA 01/2023 - 03/2011
5	CrizotinibIBA 01/2021 - 01/2019
5	CarcinogensIBA 01/2021 - 09/2012
5	Biomarkers (Surrogate Marker)IBA 01/2020 - 03/2014
5	Peptides (Polypeptides)IBA 01/2020 - 01/2015
4	Interferon Type IIBA 01/2024 - 11/2014
4	InterferonsIBA 01/2023 - 03/2014
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2023 - 06/2013
4	Messenger RNA (mRNA)IBA 01/2022 - 01/2017
4	Pattern Recognition ReceptorsIBA 01/2021 - 02/2010
4	Histones (Histone)IBA 01/2021 - 04/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2023 - 01/2020
3	Therapeutic UsesIBA 01/2022 - 06/2010
3	LigandsIBA 01/2021 - 10/2010
3	ChromatinIBA 12/2019 - 01/2013
3	InflammasomesIBA 11/2017 - 03/2012
3	Digoxin (Digitek)FDA LinkGeneric 02/2013 - 07/2012
3	Small Interfering RNA (siRNA)IBA 07/2010 - 03/2009
2	Monoclonal AntibodiesIBA 01/2024 - 12/2014
2	venetoclaxIBA 11/2023 - 10/2023
2	Poly I-CIBA 01/2023 - 01/2021
2	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2023 - 01/2022
2	LipidsIBA 01/2023 - 01/2020
2	Fatty Acids (Saturated Fatty Acids)IBA 10/2022 - 04/2015
2	Activating Transcription Factor 4IBA 01/2022 - 01/2018
2	NucleosidesIBA 01/2022 - 11/2017
2	CytokinesIBA 01/2022 - 03/2014
2	Immunoconjugates (Immunoconjugate)IBA 01/2022 - 10/2021
2	MethyltransferasesIBA 01/2022 - 12/2019
2	SpermidineIBA 01/2022 - 01/2019
2	Activating Transcription Factor 6IBA 01/2022 - 01/2018
2	Coenzyme A (CoA)IBA 01/2022 - 01/2019
2	X-Box Binding Protein 1IBA 01/2022 - 01/2018
2	Immunoglobulin G (IgG)IBA 12/2021 - 06/2013
2	RNA (Ribonucleic Acid)IBA 12/2021 - 01/2019
2	Oleic Acid (Oleate)IBA 01/2021 - 04/2015
2	Annexin A1IBA 01/2021 - 01/2019
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2021 - 11/2015
2	Green Fluorescent ProteinsIBA 01/2021 - 01/2013
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 06/2013
2	PM 01183IBA 01/2020 - 01/2019
2	Recombinant ProteinsIBA 01/2020 - 06/2013
2	Adenosine (Adenocard)FDA LinkGeneric 11/2017 - 03/2014
2	NucleotidesIBA 11/2017 - 10/2009
2	Serine-Threonine Kinase 3IBA 01/2017 - 06/2016
2	Caspase 3 (Caspase-3)IBA 06/2016 - 03/2012
2	Cytostatic AgentsIBA 12/2015 - 03/2011
2	LTX-315IBA 09/2015 - 01/2015
2	Purinergic Receptors (Receptors, Purine)IBA 04/2013 - 05/2012
2	Cardiac GlycosidesIBA 02/2013 - 12/2012
2	pyrazolanthroneIBA 01/2013 - 06/2012
2	Cytotoxins (Cytolysins)IBA 08/2012 - 10/2010

Therapy/Procedure

47	Therapeutics 01/2024 - 07/2008
37	Drug Therapy (Chemotherapy) 01/2023 - 09/2009
25	Immunotherapy 01/2024 - 12/2014
9	Radiotherapy 01/2022 - 10/2008
3	Photochemotherapy (Photodynamic Therapy) 01/2022 - 01/2018
2	Injections 01/2023 - 01/2019
2	Intravenous Injections 01/2021 - 10/2020
2	Adjuvant Chemotherapy 11/2015 - 05/2012